LCN2 and congestive heart failure: However, novel kidney biomarkers (Cys C, NGAL, KIM-1, H-FABP and NAG) have recently been evaluated in CHF patients, and their serum levels have prognostic value for not only renal outcomes but also cardiovascular outcomes7.